Abstract
New paradigms suggest that many aspects of cellular function are controlled by rapid, stochastic, combinatorial processes. The implications of these new paradigms for proteomics are considered in relation to the information content of top-down and bottom-up proteomics approaches. Functional evidence and Current Proteomics experiments suggest that phenotypic variation of individual proteins is a major form of control for the combinatorial processes and that in many cases top-down proteomics approaches will be essential for proteomics investigations of cellular function. It is suggested that the new paradigms and the nature of the general cellular processes that affect protein phenotypes should be taken into account in the development of proteomics methodology. More generally, the coupling of stochastic, combinatorial processes to energy-dependent processes that change protein phenotypes may represent one of the basic principles of cellular function.
Keywords: proteomics, mass spectrometry, hypoxia, nuclear receptors, endothelin, phosphorylation
Current Proteomics
Title: New Paradigms in Cellular Function and the Need for Top-Down Proteomics Analysis
Volume: 1 Issue: 1
Author(s): Corinne Stannard, Larry R. Brown and Jasminka Godovac-Zimmermann
Affiliation:
Keywords: proteomics, mass spectrometry, hypoxia, nuclear receptors, endothelin, phosphorylation
Abstract: New paradigms suggest that many aspects of cellular function are controlled by rapid, stochastic, combinatorial processes. The implications of these new paradigms for proteomics are considered in relation to the information content of top-down and bottom-up proteomics approaches. Functional evidence and Current Proteomics experiments suggest that phenotypic variation of individual proteins is a major form of control for the combinatorial processes and that in many cases top-down proteomics approaches will be essential for proteomics investigations of cellular function. It is suggested that the new paradigms and the nature of the general cellular processes that affect protein phenotypes should be taken into account in the development of proteomics methodology. More generally, the coupling of stochastic, combinatorial processes to energy-dependent processes that change protein phenotypes may represent one of the basic principles of cellular function.
Export Options
About this article
Cite this article as:
Stannard Corinne, Brown R. Larry and Godovac-Zimmermann Jasminka, New Paradigms in Cellular Function and the Need for Top-Down Proteomics Analysis, Current Proteomics 2004; 1 (1) . https://dx.doi.org/10.2174/1570164043488243
DOI https://dx.doi.org/10.2174/1570164043488243 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
CXCR4-CXCL12-Dependent Inflammatory Network and Endothelial Progenitors
Current Medicinal Chemistry The Interest of Folic Acid in Targeted Photodynamic Therapy
Current Medicinal Chemistry The Renin Angiotensin System in the Regulation of Angiogenesis
Current Pharmaceutical Design Delivery of Intracellular-Acting Biologics in Pro-Apoptotic Therapies
Current Pharmaceutical Design Epigenetic Modifications as Therapeutic Targets
Current Drug Targets Flavopiridol, the First Cyclin-Dependent Kinase Inhibitor: Recent Advances in Combination Chemotherapy
Mini-Reviews in Medicinal Chemistry HIV-1 Replication from After Cell Entry to the Nuclear Periphery
Current HIV Research Pregnancy, Programming and Preeclampsia: Gap Junctions at the Nexus of Pregnancy-induced Adaptation of Endothelial Function and Endothelial Adaptive Failure in PE
Current Vascular Pharmacology Revisiting the ABCs of Multidrug Resistance in Cancer Chemotherapy
Current Pharmaceutical Biotechnology The Important Roles of miR-205 in Normal Physiology, Cancers and as a Potential Therapeutic Target
Current Cancer Drug Targets Fighting Fire with Fire: A Patent for the Combined Application of Oncolytic Herpes Viruses and Antiangiogenic Agents in the Battle Against Human Cancers
Recent Patents on Anti-Cancer Drug Discovery RNA Interference-Mediated Validation of Survivin and Apollon/BRUCE as New Therapeutic Targets for Cancer Therapy
Current Topics in Medicinal Chemistry Selective Inhibitors of Zinc-Dependent Histone Deacetylases. Therapeutic Targets Relevant to Cancer
Current Pharmaceutical Design Drug Coated Clay Nanoparticles for Delivery of Chemotherapeutics
Current Nanoscience Intracellular Trafficking of Plasmids for Gene Therapy: Mechanisms of Cytoplasmic Movement and Nuclear Import
Current Gene Therapy Role of ABC Transporters in Veterinary Medicine: Pharmaco- Toxicological Implications
Current Medicinal Chemistry Neddylation Pathway as a Novel Anti-cancer Target: Mechanistic Investigation and Therapeutic Implication
Anti-Cancer Agents in Medicinal Chemistry Crosstalk Signalling Role in Modulation of Drugs Side Effects
Current Molecular Pharmacology miRNAs in Alzheimer Disease – A Therapeutic Perspective
Current Alzheimer Research Some Recent Synthetic Development on Compounds with Potent Activities on Hormone-sensitive Breast Cancers
Current Organic Chemistry